Literature DB >> 17663804

The effects of fish oil and high or low linoleic acid intake on fatty acid composition of human peripheral blood mononuclear cells.

Camilla T Damsgaard1, Hanne Frøkiaer, Lotte Lauritzen.   

Abstract

Dietary intake of 18: 2n-6 and 18: 3n-3 may affect endogenous production and incorporation of n-3 long-chain PUFA (LCPUFA) from fish oils (FO). This double-blinded controlled 2 x 2-factorial 8-week intervention investigates the effects of high and low 18: 2n-6 intake in combination with FO-supplementation on tissue fatty acid composition. Healthy young men (n 64) were randomized to capsules with FO or olive oil (control) (4.4 (2.0-5.6) ml/d) and to either sunflower oil and margarine (S/B) or rapeseed oil and a butter spread (R/K) to provide a high or a low 18: 2n-6 intake. Diet was measured by 4-d weighed dietary records at baseline, during and 8 weeks after the intervention and tissue incorporation as fatty acid composition of peripheral blood mononuclear cells (PBMC). The fat intervention gave a mean difference in the 18: 2n-6 intake of 7.3 g/d (95 % CI 4.6, 10.0) and a similar 18: 3n-3 intake in the groups. The R/K groups had a 0.2 % fatty acid (FA%) (95 % CI 0.0, 0.4, P = 0.02) higher content of 22: 5n-3 in the PBMC, a tendency of slightly higher 20: 5n-3 (P = 0.06), but no more 22: 6n-3 (P = 0.83) than the S/B groups. FO effectively raised the PBMC content of all n-3 LCPUFA (P < 0.001). The fat intervention did not markedly influence the effect of FO; the mean PBMC content of n-3 LCPUFA was 10.3 (sem 0.3) FA% in the FO+S/B group and 10.6 (sem 0.2) FA% in the FO+R/K group. In conclusion, increasing the 18: 2n-6 intake did not have any pronounced effect on incorporation of n-3 LCPUFA in PBMC, either alone or with simultaneous FO supplementation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17663804     DOI: 10.1017/S0007114507791900

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  9 in total

1.  n-3 polyunsaturated fatty acids suppress CD4(+) T cell proliferation by altering phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P2] organization.

Authors:  Tim Y Hou; Rola Barhoumi; Yang-Yi Fan; Gonzalo M Rivera; Rami N Hannoush; David N McMurray; Robert S Chapkin
Journal:  Biochim Biophys Acta       Date:  2015-10-23

Review 2.  n-3 polyunsaturated fatty acids--physiological relevance of dose.

Authors:  Wooki Kim; David N McMurray; Robert S Chapkin
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-02-25       Impact factor: 4.006

3.  n-3 polyunsaturated fatty acids suppress phosphatidylinositol 4,5-bisphosphate-dependent actin remodelling during CD4+ T-cell activation.

Authors:  Tim Y Hou; Jennifer M Monk; Yang-Yi Fan; Rola Barhoumi; Yong Q Chen; Gonzalo M Rivera; David N McMurray; Robert S Chapkin
Journal:  Biochem J       Date:  2012-04-01       Impact factor: 3.857

4.  RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials.

Authors:  Theodore R Witte; Alexander J Salazar; Oscar F Ballester; W Elaine Hardman
Journal:  Lipids Health Dis       Date:  2010-03-22       Impact factor: 3.876

5.  n3 PUFAs reduce mouse CD4+ T-cell ex vivo polarization into Th17 cells.

Authors:  Jennifer M Monk; Tim Y Hou; Harmony F Turk; David N McMurray; Robert S Chapkin
Journal:  J Nutr       Date:  2013-07-17       Impact factor: 4.798

6.  Metabolic profiling of human peripheral blood mononuclear cells: influence of vitamin d status and gender.

Authors:  Magdalena Stepien; Anne P Nugent; Lorraine Brennan
Journal:  Metabolites       Date:  2014-04-22

Review 7.  n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.

Authors:  Jennifer M Monk; Harmony F Turk; Danyelle M Liddle; Anna A De Boer; Krista A Power; David W L Ma; Lindsay E Robinson
Journal:  Nutrients       Date:  2014-10-30       Impact factor: 5.717

8.  Methodology for altering omega-3 EPA+DHA and omega-6 linoleic acid as controlled variables in a dietary trial.

Authors:  Beth A MacIntosh; Christopher E Ramsden; Gilson Honvoh; Keturah R Faurot; Olafur S Palsson; Angela D Johnston; Chanee Lynch; Paula Anderson; Daria Igudesman; Daisy Zamora; Mark Horowitz; Susan Gaylord; John D Mann
Journal:  Clin Nutr       Date:  2021-05-12       Impact factor: 7.643

9.  Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial.

Authors:  Paula S Silva; Gilberto Marcelo Sperandio da Silva; Andréa P de Souza; Claudia S A Cardoso; Cristiane A Fonseca; Patricia D Brito; Roberto M Saraiva; Pedro E A Brasil; Roberta O Pinheiro; Alejandro M Hasslocher-Moreno; Sérgio S Xavier; Andréa S Sousa
Journal:  Trials       Date:  2013-11-11       Impact factor: 2.279

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.